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MOB1 is a multifunctional protein best characterized for
its integrative role in regulating Hippo and NDR pathway
signaling in metazoans and the Mitotic Exit Network in
yeast. Human MOB1 binds both the upstream kinases
MST1 and MST2 and the downstream AGC group kinases
LATS1, LATS2, NDR1, and NDR2. Binding of MOB1 to
MST1 and MST2 is mediated by its phosphopeptide-bind-
ing infrastructure, the specificity of which matches the
phosphorylation consensus of MST1 and MST2. On the
other hand, binding of MOB1 to the LATS and NDR ki-
nases is mediated by a distinct interaction surface on
MOB1. By assembling both upstream and downstream
kinases into a single complex, MOB1 facilitates the acti-
vation of the latter by the former through a trans-phos-
phorylation event. Binding of MOB1 to its upstream part-
ners also renders MOB1 a substrate, which serves to
differentially regulate its two protein interaction activities
(at least in vitro). Our previous interaction proteomics
analysis revealed that beyond associating with MST1 (and
MST2), MOB1A and MOB1B can associate in a phosphor-
ylation-dependent manner with at least two other signal-
ing complexes, one containing the Rho guanine exchange
factors (DOCK6-8) and the other containing the serine/
threonine phosphatase PP6. Whether these complexes
are recruited through the same mode of interaction as
MST1 and MST2 remains unknown. Here, through a com-
prehensive set of biochemical, biophysical, mutational
and structural studies, we quantitatively assess how
phosphorylation of MOB1A regulates its interaction with
both MST kinases and LATS/NDR family kinases in vitro.
Using interaction proteomics, we validate the significance
of our in vitro studies and also discover that the phospho-
rylation-dependent recruitment of PP6 phosphatase and
Rho guanine exchange factor protein complexes differ in
key respects from that elucidated for MST1 and MST2.
Together our studies confirm and extend previous work to
delineate the intricate regulatory steps in key signaling
pathways. Molecular & Cellular Proteomics 16: 10.1074/
mcp.M117.068130, 1111–1125, 2017.
The Mps One Binder (MOB)1 proteins comprise an evolu-
tionarily conserved eukaryotic protein family (with sizes rang-
ing from 210–314 amino acids), whose founding member was
discovered in yeast through interaction screens with the ki-
nase Mps1 (1) and shown to be critical for mitotic exit (re-
viewed in 2, 3). Two yeast MOB proteins, Mob1 and Mob2,
exist in S. cerevisiae. They function as AGC group kinase
regulators, with Mob1 facilitating the activation of the Dbf2
kinase in the Mitotic Exit Network pathway (4, 5) and Mob2
facilitating the activation of the Cbk1 kinase in the RAM (reg-
ulation of Ace2 and morphogenesis) network pathway (6).
Drosophila Mats (Mob as tumor suppressor; also known as
dMOB1) was later identified through genetic screens in Dro-
sophila eye development and found to encode a regulator of
the Hippo pathway that controls cell proliferation and tissue
growth (7). Consistent with the function of MOB proteins as
kinase activators in yeast, Mats associates with and activates
the Dbf2-related kinase Warts (8). However, unlike in the yeast
system where Mob1 and Mob2 activate distinct kinases (Dbf2
and Cbk1), Mats, in addition to regulating Warts, also physi-
cally and functionally interacts with another AGC kinase, Tri-
cornered, which is implicated in the morphogenesis of polar-
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ized cellular extensions and is a closer ortholog of Cbk1 (9).
Additional complexity in insects arises through the presence
of three additional MOB proteins, at least one of which
(dMOB2) is also capable of physically and functionally asso-
ciating with Tricornered, which binds Warts in a yeast two-
hybrid assay (9); see Fig. 1A.
In mammals, the MOB family comprises seven members
that can be grouped into 4 sub-families, each with orthology
to one of the four Drosophila MOB proteins. Like Mats, the
96% identical MOB1A and MOB1B bind to and function to
activate the AGC kinases LATS1 and LATS2 (large tumor
suppressor) in the Hippo signaling pathway (10). This leads to
the phosphorylation of the transcriptional co-activators YAP1
and TAZ (gene nameWWTR1), and as a result, their cytosolic
sequestration away from transcriptional targets (11, 12). Im-
portantly, MOB1A and MOB1B also bind the Tricornered or-
tholog kinases NDR1 and NDR2 (nuclear Dbf2-related, gene
names STK38 and STK38L, 13, 14), though the downstream
signaling consequences of these events are less well under-
stood. Like in flies, human MOB2 can also associate with the
NDR1 and NDR2 proteins, though in an apparently different
mode from MOB1A, and with opposing consequences as it
acts as a negative regulator of these kinases (15). The other
human MOB proteins (MOB3A, MOB3B, MOB3C and MOB4)
do not appear to associate with LATS or NDR kinases (15, 16).
In addition to directly binding and allosterically activating
their downstream AGC kinase partners, MOB proteins also
facilitate their activation indirectly by bridging interactions
with Ste20 related kinases, namely Cdc15 (17) and Kic1 (18) in
yeast (through Mob1 and Mob2, respectively), Hpo (19) in
flies, and MST1 and MST2 (gene names STK4 and STK3, 20)
in mammalian cells. This bridging function of MOBs allows the
Ste20 related kinases to phosphorylate specific AGC family
kinases on positive regulatory sites within their C-terminal
regulatory tails (17, 20–25).
The molecular basis by which MOB recognizes Ste20 re-
lated kinases was revealed by the discovery of Rock et al. that
yeast Mob1 functions as a phospho-recognition module (26)
and that human MOB1A and MOB1B exploit a conserved
phospho-recognition infrastructure to bind MST1 and MST2
(27). Ni et al. (28) provided a structural view of MOB1B bound
to a phosphorylated peptide derived from MST2 (pT378). The
studies described in the accompanying manuscript (29) ex-
pand on these findings by defining the consensus binding
preference (and binding mode) of MOB1 for phosphopep-
tides. Together with the elucidated MST1 phosphorylation
consensus, this allows for a full rationalization of the redun-
dancy of phosphosites present in MST1 that mediate interac-
tion with MOB1 in a cellular context.
We note however, that MST1 and MST2 are not the only
proteins that interact with MOB1 in a phosphorylation-de-
pendent manner, and interaction proteomic analyses (27)
showed apparently mutually exclusive and phosphorylation-
dependent interaction with at least three independent protein
modules (supplemental Fig. S1), namely: (1) the upstream
Hippo kinase components including MST1 and MST2; (2) the
phosphoprotein phosphatase 6, PPP6C, and its regulatory
subunits (30, 31, here called the PP6 module); (3) a module
comprised of the atypical guanine nucleotide exchange fac-
tors (DOCK6-8, ref 32) and poorly characterized associated
proteins, including leucine rich repeats and calponin homol-
ogy domain containing (LRCH1-4) proteins and cytokine re-
ceptor like factor 3 (CRLF3). Whether the structural elements
uncovered by Rock et al. (26), Ni et al. (28), Kim et al. (33) and
the accompanying paper (29) explain the phosphorylation-de-
pendent recruitment of these additional complexes to MOB1
remains to be determined.
Importantly, in the context of the Hippo signaling pathway,
MOB1A and MOB1B are also substrates for MST1 and MST2,
with T12 and T35 acting as the predominant phosphorylation
sites (34), though additional sites have been detected in phos-
phoproteomics studies (35). Recent structural studies have
revealed a role for MOB1 phosphorylation in regulating MOB1
interaction with both upstream (Ste20) and downstream
(AGC) kinases. Kim et al. reported the crystal structure of
full-length murine Mob1b to reveal that in the absence of
phosphorylation, the N terminus of Mob1b binds in an intra-
molecular manner to its Lats1 binding surface, thereby im-
peding Lats1 kinase interaction (33). As shown in an associ-
ated manuscript (29), this autoinhibitory feature is also
employed by human MOB1A and is compatible with MOB
protein binding to optimal phosphopeptide ligands. Ni et al.
reported how the phosphorylated form of murine Mob1b
binds to Lats1. In that structure, the phosphorylated N termi-
nus of Mob1b engages its own phosphopeptide-binding in-
frastructure to expose the Lats1 binding surface, thus ena-
bling Lats1 binding. Together, these studies shed light on the
underlying binding modes and phospho-regulation mecha-
nisms governing core Hippo pathway interactions. However,
many questions of protein function and significance remain
unaddressed, most notably because these studies relied
heavily on in vitromodels, with in vivo validation only provided
in the context of the yeast Cbk1-Mob2 complexes (36).
In this study, we performed an in-depth characterization of
the role of the MOB1 phosphorylation on its interaction with
both the upstream MST1 and MST2 kinases and the down-
stream LATS and NDR family kinases. We show that MST
kinase-generated phosphosites in MOB1 are suboptimal
compared with its phosphopeptide-binding consensus. We
also show that substitution of these suboptimal phosphosites
with a sequence better matching the optimal binding consen-
sus determined in the accompanying paper (29) has an impact
on the ability of MOB1 to autoregulate its interactions in cells.
Lastly, our proteomics cell-based studies reveal that MOB1
likely employs different modes of action to engage molecular
complexes such as PP6 and DOCK6-8 as compared with
MST1 and MST2, which hints at further complexities for future
investigation.
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EXPERIMENTAL PROCEDURES
Recombinant Protein Expression and Purification—NDR1 (amino
acids 12–418, NP_009202.1), MOB1A (2–216, NP_060691) wild type
and indicated MOB1Amutant proteins were expressed in E. coli BL21
(DE3) CodonPlus RIL cells as N-terminal dual 6xhistidine (HIS) and
glutathione S-transferase (GST) Tobacco Etch Virus (TEV) cleavable
fusion proteins using a modified pETM-30 vector. MOB1A wild type
and mutants were purified in batch on glutathione-Sepharose resin
and eluted by cleavage from the affinity tags with HIS tagged TEV
protease. TEV protease was removed from the eluted protein by
subtractive immobilized-metal affinity chromatography. Cleaved pro-
tein was then concentrated and buffer exchanged by size exclusion
chromatography (SEC) using a Superdex 75 120 ml column (GE
Healthcare, Uppsala, Sweden).
Crystallization and Data Collection—Crystals of purified MOB1A in
the space group C2221 (a  86.1, b  86.2, c  138.1, alpha  90,
beta  90, gamma  90) with two molecules in the asymmetric unit
were obtained using the hanging drop method by mixing protein (at 7
mg/ml) and precipitant solution (0.1 M MES pH 5.5, 0.2 M NH4Cl, and
20% PEG 6000) in a 1:1 ratio.
For diffraction studies, all protein crystals were flash-frozen in
mother liquors supplemented with 20–25% (v/v) ethylene glycol.
Diffraction data collection was performed at the NE-CAT beamline
24-ID-E (Advanced Photon Source, Argonne National Laboratory,
Argonne, IL).
Structure Solution and Refinement—X-ray data sets were pro-
cessed using HKL2000 software (37). The MOB1A structure was
solved by molecular replacement with Phaser - CCP4i using the
MOB1A core domain (38, PDB ID: 1PI1) as a search model. Model
autobuilding was carried out in Buccaneer to build the N-terminal
extension of the MOB1A (39). The final structure model generated by
iterative model building in COOT (40) was refined using Refmac (41).
See supplemental Table S3 for data collection and model refinement
statistics. The crystal structure of full-length human MOB1A in its apo
state was deposited with the Protein Data Bank under the PBD code
5TWF.
Peptides for Biophysical Studies—FITC labeled nonphosphor-
ylated and phosphorylated variants of MST1 T353 peptide
(FITC-VASTMTDGAN(p)TMIEH), T367 peptide (FITC-DDTLPSQLG(p)
TMVINA), MOB1A T12 peptide (RSSK(p)TFKPKKNIPEG), MOB1A T35
peptide (FITC-AEA(p)TLGSGNLRQAVM) and MOB1A12–38 peptide
(FITC-RSSK(p)TFKPKKNIPEG) for fluorescence polarization binding
experiments were purchased from Biomatik (Cambridge, ON).
Fluorescence Polarization Peptide Binding Assay—Twelve-point
fluorescence polarization binding measurements were performed in
triplicate in 384-well plate format using an Analyst HT (Artisan-Scien-
tific, Sunnyvale, CA) reader. Each 20 l measurement condition con-
tained 20 nM FITC labeled MST1 peptide and the indicated concen-
tration of MOB1 protein in 25 mM HEPES pH 7.5, 150 mM NaCl, 2 mM
DTT, and 1 mg/ml bovine serum albumin (BSA). For competitive
displacement assays, each 20 l measurement condition contained
350 M MOB1A core domain (residues 52–216), 20 nM FITC-
MOB1A21–38 probe (giving rise to80% saturated binding signal) and
the indicated concentration of competitor protein, NDR112–418. Kd
and IC50 values were obtained by fitting the results to a one-site
specific binding model using GraphPad Prism.
Microscale Thermophoresis—MOB1A-NDR1 binding studies were
performed in triplicate using a Monolith NT.115 (Nanotemper Tech-
nologies, Munich, Germany) according to manufacturer’s instruc-
tions. Briefly, recombinant WT and mutant MOB1A proteins were
labeled with the RED-NHS (amine reactive) protein labeling kit (Nano-
temper Technologies). 50 nM of labeled WT or mutant MOB1A were
mixed with the indicated concentrations of unlabeled NDR112–418 in
20 mM Tris pH 8.0, 150 mM NaCl, 1 mM TCEP, 0.05% Tween-20 and
0.1% BSA, incubated for 10 min at room temperature, and loaded
into premium capillaries. Measurements were conducted at 20 to
30% laser power and 30% LED power. Kd values were obtained by
fitting the results to a one site-specific binding model using GraphPad
Prism.
Analytical ultracentrifugation (AUC)—Sedimentation-velocity AUC
was performed with a Beckman ProteomeLab XL-1 at 169,000 r.c.m.
Data were obtained after 7.5 h of centrifugation at 20°C by monitoring
the relative refractive index between sample and blank. Various con-
centrations of MOB1AWT, ranging from 20 M to 150 M, were tested
minimally in duplicate in AUC buffer (25 mM HEPES, pH 7.5, 100 mM
NaCl, and 2 mM DTT). AUC data was processed using Sedfit software
(NIH, Bethesda, MD).
Western blot—Samples were resolved on 10% SDS-polyacryl-
amide gel electrophoresis and transferred onto a nitrocellulose mem-
brane, probed with the primary antibodies as indicated in legends,
followed by fluorescent secondary antibodies for mouse (CW800,
LICOR, Lincoln, NE) or rabbit (CW680, LICOR), and then directly
imaged on an Odyssey scanner (LI-COR). LATS antibody was from
Cell Signaling Technology (#9153), PPP6C antibody was previously
described (27) and anti-tubulin was from the Developmental Studies
Hybridoma Bank at the University of Iowa.
Stable Human Cell Line Generation for MOB1A mutants—3xFLAG
tagged MOB1A constructs were generated via Gateway cloning into
pDEST 5 Triple FLAG pcDNA5 FRT TO. The accession number for
the starting clone was BC003398. Point mutations were generated by
polymerase chain reaction-directed mutagenesis (the position of the
mutated amino acids is indicated on the basis of the reference se-
quence). All constructs were sequence verified. Stable cell lines were
generated as Flp-In 293 T-REx cell pools as described (42), and
expression was induced for 24 h with tetracycline (1 g/ml). Okadaic
acid was added at a concentration of 150 nM for 2.5 h unless other-
wise indicated, and DMSO was used as a negative control.
FLAG Affinity Purification Coupled with Mass Spectrometry (AP-
MS) for MOB1A Mutants—Cell pellets from one 150 mm plate were
lysed in 50 mM Hepes-KOH (pH 8.0), 100 mM KCl, 2 mM EDTA, 0.1%
Nonidet P-40, and 10% glycerol and affinity-purified with M2-FLAG
magnetic beads and on-bead digestion as described (42). Peptides
were analyzed by nano-LCMS using a home-packed 0.75 m  10
cm C18 emitter tip (Reprosil-Pur 120 C18-AQ, 3 m). A NanoLC-Ultra
HPLC system (Eksigent, Dublin, CA) was coupled to an LTQ Orbitrap
Velos (Thermo Fisher Scientific, Waltham, MA) and samples were
analyzed in data-dependent acquisition mode. A 60,000 resolution
MS scan was followed by 10 CID MS/MS ion trap scans on multiple
charged precursor ions with a dynamic exclusion of 20 s. The LC
gradient was delivered at 200 nl/m and consisted of a ramp of
2–35% acetonitrile (0.1% formic acid) over 90 min, 35–80% ace-
tonitrile (0.1% formic acid) over 5 min, 80% acetonitrile (0.1%
formic acid) for 5 min, and then 2% acetonitrile for 20min. This data set
consisting of 26 raw files and associated peak list and results files has
been deposited in ProteomeXchange through partner MassIVE as a
complete submission and assigned the MassIVE ID MSV000080331
and PXD005327, ftp://massive.ucsd.edu/MSV000080331.
MS Data Analysis For FLAG AP-MS For MOB1A Mutants—Raw
files were converted to mzXML and mgf files using ProteoWizard
3.0.4468 (43) and analyzed using the iProphet pipeline (44) imple-
mented within ProHits (45) as follows. The database consisted of the
human and adenovirus sequences in the RefSeq protein database
(version 57) supplemented with “common contaminants” from the
Max Planck Institute (http://141.61.102.106:8080/share.cgi?ssid
0f2gfuB) and the Global Proteome Machine (GPM; http://www.thegpm.
org/crap/index.html). The search database consisted of forward and
reverse sequences (labeled “gi 9999” or “DECOY”); in total, 72,226
entries were searched. Spectra were analyzed separately using Mas-
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cot (2.3.02; Matrix Science) and Comet [2012.01 rev.3 (46)] for trypsin
specificity with up to two missed cleavages; deamidation (Asn or Gln)
and oxidation (Met) as variable modifications; the mass tolerance of
the precursor ion was set at12 parts per million (ppm), the fragment
ion tolerance at  0.6 amu. The resulting Comet and Mascot results
were individually processed by PeptideProphet (47) and combined
into a final iProphet output using the Trans-Proteomic Pipeline (TPP;
Linux version, v0.0 Development trunk rev 0, Build 201303061711).
TPP options were as follows: general options were -p0.05 -x20 -d
“gi 9999,” iProphet options were -ipPRIME, and PeptideProphet op-
tions were -OpdP. All proteins with a minimal iProphet probability of
0.05 were parsed to the relational module of ProHits. For analysis with
SAINT, only proteins with an iProphet protein probability of 0.95
were considered. Hits were also restricted to those detected with a
minimum of two unique peptides.
Interaction Scoring For FLAG AP-MS MOB1A Mutants—For each
bait protein, one plate per cell line was treated with 150 nM okadaic
acid in DMSO or with DMSO alone for 2.5 h before harvesting.
Samples were prepared for MS analysis, as described above, in
biological duplicate from cells grown, treated, and processed at dif-
ferent times to maximize the variability and increase the robustness in
the detection of true interactors. Cells expressing the FLAG tag alone
were used for negative controls and processed in parallel to mitigate
“batch effect” artifacts (48). The quality of each sample was assessed
by manually aligning the runs for the biological replicates in ProHits.
Samples of low quality were discarded, and additional biological
replicates were acquired. SAINTexpress version 3.6.1 was used with
default options (49). Six negative control experiments (three treated
with DMSO and three treated with OA) were compressed to 4 virtual
controls for SAINTexpress scoring to increase robustness (as in ref
49). Proteins with FDR of 1% were considered true positive inter-
actions. Fold change was calculated for each prey protein as the ratio
of average spectral counts from replicate bait purifications over the
average spectral counts across all negative controls (peptide spectral
counts were summed for each protein, ref 50). Visualization of the
interactions as dot plots was through prohits-viz.lunenfeld.ca, and
was first introduced in (51); once a particular prey passes the selected
FDR threshold for at least one bait, all the quantitative data across all
baits are retrieved and displayed. On these dot plots, the color
intensity maps to the averaged spectral counts across both replicates
(capped at a maximal value), whereas the size of the circles is pro-
portional to the maximal spectral count value for the bait across
all samples analyzed in parallel. The confidence score from SAINT-
express is mapped as the edge color.
Determination of the Specificity of Human MOB/AGC Kinase Inter-
actions by AP-MS—Human MOBs and NDR/LATS kinases were
cloned into pcDNA3-FLAG and pcDNA3–3HA (16) from cDNA col-
lections and match following NCBI RefSeq entries: MOB1A
(NP_060691), MOB1B (NP_001231695), MOB2 (NP_001165694),
MOB3A (NP_570719), MOB3B (NP_079037), MOB3C (NP_660322),
MOB4 (NP_056202). The NDR1 D212A, NDR2 D213A, LATS1 D828A,
and LATS2 D791A kinase dead point mutations were generated by
overlap extension PCR and constructs were sequenced.
For each biological replicate, stable pools of FLAG-tagged HEK293
(generated as in ref 42) were grown in five 15 cm plates to 80%
confluency before harvesting in ice-cold PBS using a rubber spatula.
After pelleting the cells by centrifugation and washing them once in
ice-cold PBS, the cell pellets were frozen on dry ice. The frozen cell
pellets were resuspended in ice-cold lysis buffer (50 mM HEPES-
NaOH pH 8.0, 100 mM KCl, 2 mM EDTA, 10 mM NaF, 0.1% Nonidet
P-40, and 10% glycerol), supplemented with 1 mM PMSF, 1 mM DTT
and 1 protease inhibitor mixture (Sigma-Aldrich, St. Louis, MO) at a
1:4 pellet weight: volume ratio. Phosphatase inhibitors were freshly
added to the lysis buffer (50 mM -glycerolphosphate, 5 nM okadaic
acid and 5 nM calyculin). Cells were lysed on a nutator at 4°C for 10
min. One freeze-thaw cycle was performed by incubating the tube on
dry ice for 10 min, then transferring it to a 37°C water bath with
agitation, then storing it on ice. The sample was spun down to remove
cell debris from the sample (20 min at 16,000  g, 4°C). The
supernatant was transferred to a tube containing pre-washed anti-
FLAG M2 agarose beads (A2220, Sigma-Aldrich; 7.5l packed beads
per experiment). Immunoprecipitation was performed for 3 h at 4°C
with gentle agitation on a nutator. Beads were pelleted by centrifu-
gation (500  g for 1 min) and the supernatant was removed. The
beads were transferred to a 1.5 ml disposable column and washed
three times in 1 ml lysis buffer and three more times with FLAG rinsing
buffer (50 mM NH4HCO3, pH 8.0 and 75 mM KCl) by forcing buffer
through the column with a pipette bulb. Proteins were eluted 3 times
by adding 150 l of elution buffer (0.5 M NH4OH, pH 11.0–12.0),
flicking the column to mix and incubating for 2–5 min at room tem-
perature and the eluate was collected in a microfuge tube. The eluate
was lyophilized in a centrifugal evaporator. To ensure removal of any
remaining NH4OH, which may impede trypsin digestion, the sample
was washed with 200 l of water and lyophilized again.
Proteins were digested with 750 ng trypsin (T6567, Sigma-Aldrich)
at 100 ng/l in 50 mM NH4HCO3, pH 8.0 overnight at 37°C. The next
day, 250 ng trypsin was added to continue the digestion for another
2–3 h. Formic acid was added to the sample to a final concentration
of 2% (from 50% stock solution) and the mixture was lyophilized in a
centrifugal evaporator. The lyophilized peptides were resuspended in
20 l of HPLC reversed-phase buffer A (2% acetonitrile, 0.1% formic
acid), spun down, and transferred to a fresh tube. The samples were
either stored at 20°C or directly loaded (6 l) onto a column for
analysis by mass spectrometry.
Microcapillary reversed-phase columns (75-m inner diameter,
363-m outer diameter; Polymicro Technology, Phoenix, AZ) were
cut to a final length of 15–20 cm, and spray tips were pulled in-house
by hand. Columns were packed in-house (12 cm) with Magic C18
100-Å, 5-m silica particles (Michrom, Auburn, CA) using a pressure
bomb. Prior to loading the sample, columns were equilibrated in
HPLC buffer A. Sample was applied to the column using a pressure
bomb and then washed off line in buffer A for 10 min. The loaded
column was then placed in-line with a LTQ mass spectrometer
equipped with an Agilent 1100 pump with split flow and a Proxeon
source. Buffer A is 2% ACN, 0.1% formic acid; buffer B is 98% ACN,
0.1% formic acid. The HPLC gradient program delivered an acetoni-
trile gradient (5–14% acetonitrile over 5 min, 14–40% over 60 min,
and 40–80% over 10 min). The parameters for data dependent ac-
quisition on the mass spectrometer were: 1 centroid MS (mass range
400–2000) followed by MS/MS on the 2 most abundant ions. General
parameters were: activation type  CID, isolation width  3, normal-
ized collision energy  32, activation Q  0.25, activation time  30
msec, wideband activation. For data dependent acquisition, minimum
threshold was 1000, the repeat count  1, repeat duration  30 s,
exclusion size list  500, exclusion duration  30 s, exclusion mass
width (by mass)  low 1.2, high 1.5.
Mass spectrometry data was stored, searched and analyzed using
the ProHits laboratory information management system (LIMS) plat-
form, through conversion with ProteoWizard and analysis through
Mascot, Comet and the Trans-Proteomic Pipeline against the modi-
fied RefSeq database (version 57) defined above, with the exception
that the charges 	2, 	3, and 	4 were considered, with the parent
mass tolerance set at 3 amu and a fragment ion tolerance at  0.6
amu. Two unique peptides ions and a minimum iProphet probability
of 0.95 were required for protein identification.
SAINTexpress version 3.3 used as a statistical tool to calculate the
probability value of each potential protein-protein interaction from
background contaminants (see above). Thirteen negative controls
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consisting of cells expressing the tag alone (please note that some of
these controls were used for a previous publication, ref 52) were used
for statistical assessment: they were compressed to five virtual con-
trols (50). Spectral counts for MOB, LATS, and NDR proteins were
extracted alongside the SAINT significance across both biological
replicates and used in Fig. 1B (data visualized with tools first defined
in ref 51) and supplemental Table S2. Because NDR1 (STK38) is
frequently identified as a contaminant in FLAG affinity purifications
(50), a separate set of stable cells expressing HA-tagged versions of
the MOB proteins and the kinases were generated and used to profile
interactions in one additional experiment as described above, ex-
cept that the anti-HA beads (A2095; Sigma-Aldrich, St. Louis, MO)
were used for affinity purification. Since a single control purification
was included as part of this project, we supplemented this control
with controls from the CRAPome (50, CC51–54 were used), com-
pressed them to two virtual controls and performed SAINTexpress
analysis as above. Spectral counts for MOB, LATS, and NDR pro-
teins were extracted alongside the SAINT significance across both
biological replicates and included in supplemental Table S3. Com-
plete results have been deposited in ProteomeXchange through
partner MassIVE as a complete submission and assigned the Mas-
sIVE ID MSV000080570 and PXD005966, ftp://massive.ucsd.edu/
MSV000080570.
The data is further available at ProHits-web.lunenfeld.ca (project:
“phospho-dependent Hippo interactions”).
Intact Mass Determination by Mass Spectrometry—The phosphor-
ylation status of wild type and mutant MOB1A proteins were deter-
mined using ESI-LC/MS at the AIMS Mass Spectrometry Laboratory
in the Department of Chemistry at the University of Toronto. 20 l of
200 M protein samples in 25 mM HEPES pH 7.5, 100 mM NaCl, and
2 mM DTT were submitted for analysis. Samples were diluted in water
1000-fold prior to analysis using an Agilent 6538 Q-TOF interfaced to
a 1290 ultrahigh pressure HPLC. A list of the ionic formulae was
generated by Molecular Formula Generation Algorithm as imple-
mented in the MassHunter data processing software. The Molecular
Formulae Generation Score considers the best match for the mass
accuracies and relative abundances of the isotopomers identified for
the target isotopic envelop. The standard m/z acquisition range for
biomolecules analysis was set between 200–2000 Da; however, the
mass spectra shown were expanded to highlight the appropriate
regions of interest. The reconstructed mass spectra were generated
by the Maximum Entropy algorithm in a plot of neutral mass (Da)
versus intensity. Special peaks were labeled with mass values
rounded to one decimal place. The term “deconvolute” used in the
figures refers to the process of spectral reconstruction employed in
the MassHunter BioConfirm software package.
Experimental Design and Statistical Rationale—For the interaction
studies using MOB1A mutants, biological duplicates were employed,
and statistical scoring against six negative controls (compressed to
four) was performed using Significance Analysis of INTeractome
(SAINT) as described in “Interaction Scoring for AP-MS.” For the data
presenting the specificity of interaction between MOB, LATS and
NDR proteins, the thirteen negative controls were compressed to five
virtual controls. Average SAINT score was used to determine the
Bayesian FDR, which therefore requires a high confidence interaction
across both biological replicates.
RESULTS
Interactions Between Human MOB Proteins and NDR and
LATS Kinases Defined by Interaction Proteomics—Previous
work in flies (9) and human cell lines (13, 14) revealed speci-
ficity in the association of specific MOB family members with
AGC family kinases. However, these studies were often per-
formed with overexpression of both partners or by yeast
two-hybrid analysis. To verify in a cellular system the speci-
ficity of interactions between the seven human MOB proteins
and the four related AGC group kinases LATS1, LATS2, NDR1
and NDR2, we generated stable cell lines that expressed a
FLAG-tagged version of each protein, with the kinases in both
wild type and kinase-dead forms. Affinity purification (using
anti-FLAG coupled to agarose resin) was performed in bio-
logical duplicates, and the precipitates analyzed by mass
spectrometry. The reciprocal nature of the experimental setup
served to eliminate false positives in our dataset, whereby in
one case the MOB protein is tagged and expressed in cells at
relatively low levels and the endogenously expressed protein
interactors are identified, and vice versa for the kinases. Con-
sistent with previous data, MOB1A and MOB1B recovered
both LATS and NDR family kinases, while MOB2 only recov-
ered the two NDR kinases (Fig. 1B; supplemental Table S1).
LATS only recovered peptides for MOB1A/B (though they did
not pass our significance threshold), while the NDR kinases
recovered MOB2 and the kinase-dead mutant of NDR2 re-
covered proportionally large amounts of MOB1A/B. None of
the other MOB proteins precipitated significant amounts of
LATS or NDR kinases nor were they themselves recovered
through precipitation of the kinases (Fig. 1B and supplemental
Table S1). Because NDR1 (STK38) is a frequent contaminant
in FLAG purification experiments (50), we also analyzed one
biological replicate of cells stably expressing HA-tagged ver-
sions of these proteins, and this confirmed our FLAG data
(supplemental Table S2). Together, these results confirmed
the specificity of the MOB1-LATS interaction and the MOB1
or 2-NDR interaction. To further investigate the interaction
between MOB1 and AGC group kinases below, we employed
NDR1 as a representative model for our in vitro MOB1 inter-
action studies, as it was producible in ample quantities in
bacteria, in contrast to the human LATS kinases.
Nonphosphorylated Full-length Human MOB1A Adopts an
Autoinhibitory Conformation that Occupies the NDR1 Kinase
Binding Site—Kim et al. showed that the N-terminal extension
of murine Mob1b in its dephophorylated state occludes the
projected AGC group kinase-binding site and that this inhi-
bition can be relieved in vitro by phosphomimetic mutations
of T12 and T35 within the N-terminal extension or by dele-
tions within this region (33). We observed the same autoin-
hibitory conformation of the N-terminal extension of human
MOB1A while bound to high affinity phosphopeptide ligands
from MST1 (see accompanying manuscript by 29), and
also in a newly determined 3.1 Å X-ray crystal structure of
human MOB1A in its apo state (Fig. 2A and supplemental
Table S3).
In brief, in the apo crystal structure of nonphosphorylated
full length human MOB1A, the N-terminal extension preceding
the core domain forms a 4-turn -helix (residues 24 to 38
denoted helix -1) followed by a short 1-turn helix (residues
41 to 45 denoted helix 0). These elements buttress against
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the MOB1A core in cis on a surface shown previously to
mediate binding to the AGC group kinases (Note that residues
1 to 22 of MOB1 are disordered, also see ref 28, 36). Although
the conformation of the N-terminal region of human MOB1A is
in agreement with that reported for murine Mob1b (Fig. 2A, 2B
and supplemental Fig. S2A, also see 33), it differs greatly from
that reported for the yeast protein (53), where the correspond-
ing N-terminal region participates in the homodimerization of
yeast Mob1 (supplemental Fig. S2B). Consistent with the
conformation in the apo crystal structure (Fig. 2A) and the
behavior of isolated murine Mob1b in solution (33), human
MOB1A in isolation was a monomer in solution as assessed
by analytical ultracentrifugation (supplemental Fig. S3).
We predicted that the observed intramolecular mode of
interaction between the human MOB1A core and the non-
phosphorylated N-terminal extension would sterically impinge
on the binding of MOB1A to NDR1 (as inferred in Fig. 2B and
Fig. 3A), a prediction Kim et al. also made for murine Mob1b
binding to murine Lats1 (28). To investigate the influence of
the N-terminal extension of MOB1A on protein function, we
first synthesized a FITC-labeled peptide corresponding to
helix -1 residues 21–38 (denoted FITC-MOB1A21–38), and
tested it for binding to a series of MOB1A deletion constructs
in trans using a fluorescence polarization assay (Fig. 2C, 2D).
Consistent with expectations, the FITC-MOB1A21–38 peptide
bound to MOB1A deletion mutants lacking the first 38 and 51
N-terminal residues. Binding, however, was appreciably
weaker ( 5-fold) for MOB1A proteins harboring the full length
N-terminal extension or a deletion mutant lacking the first 13
N-terminal residues, both of which could satisfy N-terminal
binding to the core domain of MOB1A in cis.
Next, we took advantage of FITC-MOB1A21–38 binding to
the MOB1A core domain in trans to monitor the ability of the
MOB1A core to bind downstream NDR1 kinase using a com-
petitive displacement assay. For this, we titrated unlabeled
NDR1 (12–418) into the preformed complex of FITC-
MOB1A21–38 and MOB1A52–216. We observed that increasing
concentrations of NDR1 could effectively displace the FITC-
MOB1A21–38 peptide, consistent with our inference that the
N-terminal extension of MOB1A occupies the same surface
on the core domain as NDR1 (Fig. 2E). Thus, we concluded
that the crystal structure of full-length MOB1A was reflec-
FIG. 1. Specificity of interactions between MOB proteins and AGC kinases. A, Evolution of the interactions between MOB1, MOB2, and
AGC family kinases. In S. cerevisiae, Mob1 and Mob2 contribute to the activation of different pathways through interactions with Dbf2 and
Cbk1, respectively. In Drosophila and mammals, the Mob2 ortholog preferentially associates with Cbk1-related kinases while the Mob1
ortholog can associate with both Dbf2- and Cbk1- related kinases. MOB and kinases are colored to indicate their orthology to the yeast
proteins; see text for details. B, Specificity of interaction between human MOB proteins and the indicated AGC kinases detected by affinity
purification coupled to mass spectrometry from stable cell pools. Given the high identity between MOB1A and MOB1B, we could not uniquely
assign peptides to either protein, and thus labeled them prey-wise as MOB1A/B. Also note that expression of wild-type LATS1 was not
detected in the transfected pools and thus this data is not presented here. See Supplemental Tables 1 and 2 for the spectral count table and
for the results from the HA-tagged experiment.
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tive of a protein conformation sampled in solution wherein
the N-terminal extension engages the core domain of
MOB1A in a manner that can competitively impede binding
of NDR1.
Phosphorylation of MOB1 by MST1 on T12 and T35 Facil-
itates Binding to NDR1 and Represses MOB1 Binding to
MST1 Phosphopeptides—We determined by intact mass
spectrometry that recombinant MST1 could efficiently and
stoichiometrically phosphorylate bacterially expressed MOB1A
in vitro on two sites. We confirmed the sites as being T12 and
T35 within the N-terminal extension by mutational analysis
followed by in vitro kinase reactions and intact mass mea-
surements (supplemental Fig. S4A). Both T12 and T35 sites in
MOB1A closely match the MST1 phosphorylation consensus
determined in the accompanying paper (29; supplemental Fig.
S5A). We next tested the effect of MOB1A phosphorylation on
the ability of full length MOB1A to interact with FITC-
MOB1A21–38. Strikingly, the binding affinity of phosphorylated
full length MOB1A for the FITC-MOB1A21–38 peptide was
enhanced relative to the nonphosphorylated form, to a level
comparable to MOB1A
51 (Fig. 2D). This finding suggested
that MOB1A phosphorylation could drive a change in the
conformation of the N-terminal extension to increase the in-
teraction potential of the core domain to nonphosphorylated
ligands (in this case FITC-MOB1A21–38, but by inference tar-
gets such as NDR1 which engage the same surface).
FIG. 2. Full-length nonphosphorylated MOB1A adopts an autoinhibitory conformation that impedes NDR family kinase binding. A,
Crystal structure of full-length nonphosphorylated human MOB1A. N-terminal regulatory extension highlighted in red, linker region in orange,
and core domain in green. B, Superimposition of full length nonphosphorylated human MOB1A and the yeast Cbk1251–756 (human NDR1
ortholog)-Mob245–287 (human MOB1 ortholog) complex (PDB 4LQS) (36). Note the steric clash between the nonphosphorylated N-terminal
extension of MOB1A and the MOB1 binding domain (MBD) of CBK1. C, Domain architecture of wild-type MOB1A and the N-terminal truncation
mutants used in the following panels. D, The N-terminal extension of MOB1A binds to the core domain of MOB1A in trans. Fluorescence
polarization measurement of the binding affinities between MOB1A N-terminal truncation mutants and a FITC-MOB1A21–38 peptide. Data
is plotted as the mean  S.E. (n  3). E, The N-terminal extension of MOB1A competes for the same surface on the MOB1A core domain
as NDR1. Fluorescence polarization measurement of the displacement of FITC-MOB1A21–38 peptide from MOB1A
52 (core domain) by
NDR112–418. Data is plotted as the mean  S.E. (n  3).
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Comparison of the crystal structure of nonphosphorylated
human MOB1A presented here to the crystal structure of the
T12 and T35 doubly phosphorylated MOB1B solved previ-
ously (28) hinted at the basis for the underlying phosphoryla-
tion-dependent conformational change (Fig. 3A). Engagement
of the T12 phosphosite by the phospho-binding pocket on
one surface of MOB1A would partially displace downstream
portions of the N-terminal extension from their autoinhibitory
position on the opposite surface of MOB1A due to the short-
ness of the intervening sequence (i.e. there are only eight
residues available to span a path greater than  28Å). Phos-
phorylation of the T35 site in contrast would likely destabilize
the autoinhibitory conformation of the N-terminal tail both by
steric effects arising from the bulkiness of the phosphate
moiety and by disruption of hydrophobic interactions (supple-
mental Fig. S5B).
We next investigated the consequence of MOB1 phosphor-
ylation on the ability of MOB1 to bind phosphopeptide ligands
derived from MST1 in vitro. Consistent with the ability of the
T12 site to occupy the MOB1B phospho-binding pocket in
cis in response to phosphorylation, phospho-MOB1A dis-
played a 50-fold reduction in binding affinity for MST1 phos-
phopeptides in trans relative to nonphosphorylated MOB1A
(Fig. 3B; please note that the measurements for the unphos-
phorylated MOB1 protein are from 29). Thus, the phosphoryl-
ation of MOB1A on the T12 and T35 sites appeared to both
FIG. 3. Phosphorylation on T12 and T35 induces switch-like conformational changes in MOB1A. A, Superimposition of full-length
nonphosphorylated human MOB1A onto the human pMOB1B10–212 - LATS1602–704 complex (PDB 5BRK) (28). Colors for nonphosphorylated
MOB1A are as in Fig. 2A. The N-terminal extension of pMOB1B10–212 is shown in blue; LATS1 in gray. B, Phosphorylation of MOB1A
reduces its binding affinity for MST1 phosphopeptides. Fluorescence polarization analysis of MOB1A and phospho-MOB1A binding to
MST1 pT353 and pT367 peptides. Data is plotted as the mean  S.E. (n  3). Note that the measurements for the unphosphorylated MOB1
protein are from (29). C, Phosphorylation of T12 and T35 sites in MOB1A collaborate to reduce binding affinity for MST1 phosphopeptides.
Fluorescence polarization analysis of the binding of MOB1A mutants to MST1 phosphopeptides. Data is plotted as the mean  S.E.
(n  3).
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potentiate binding of the downstream NDR1 kinase while
attenuating interaction with the upstream MST1 and MST2
kinases.
Relative Importance of T12 and T35 Site Phosphorylation in
Downregulating MOB1 Phosphopeptide Binding—The rela-
tive importance of T12 and T35 site phosphorylation in regu-
lating the phosphopeptide binding function of MOB1 has not
been extensively explored. However, the crystal structure of
phosphorylated human MOB1B (28) suggested that phosphor-
ylation of the T12 site would exert a more pronounced effect
as this residue directly occupies the phosphopeptide binding
pocket of MOB1B (28). To investigate the relative importance
of site phosphorylation on the ability to regulate MOB1 bind-
ing to MST1 phosphopeptides, we generated and functionally
characterized alanine mutations at each site. In contrast to
MOB1AWT protein, which displayed a 50-fold loss of binding
to MST1 phosphopeptides in response to MOB1A phos-
phorylation by MST1, the T35A MOB1A mutant (denoted
MOB1AT35A) with the T12 site intact displayed no loss in
binding whereas the T12A MOB1A mutant (denoted
MOB1AT12A) with the T35 site intact displayed an intermediate
6-fold loss of binding (Fig. 3C and supplemental Fig. S4A).
These results indicated that the ability of MOB1A phosphor-
ylation to maximally downregulate MST1 phosphopeptide
binding was dependent on the concerted action of both T12
and T35 site phosphorylation.
The observation that the MOB1AT12A mutant retained some
regulatory function whereas the MOB1AT35A mutant did not
was surprising since this implied that the T35 phosphosite on
its own was more competent at occupying the MOB1 phos-
phopeptide binding pocket than the phospho-T12 site, an
apparent contradiction to expectations from the crystal struc-
ture (28). We reason that the displayed binding preference for
the phospho-T12 site ‘in crystallo’ might reflect an artifact of
crystallization, or alternatively, that the T35 phosphosite does
engage the phosphopeptide-binding pocket of MOB1, but
only in the absence of T12 phosphorylation (Fig. 3C). The
contrasting behavior of the single site MOB1A mutants in vitro
raised the intriguing possibility that differential phosphoryla-
tion of MOB1 could be exploited for graded signaling re-
sponses in a cellular context.
Relative Importance of N-terminal Extension Features
and Phosphorylation in Regulating MOB1 Interaction with
NDR1—We next investigated the effect of several N-terminal
extension mutations in MOB1A on binding to the downstream
kinase NDR1 using microscale thermophoresis. MOB1A pro-
teins were labeled with RED-MALEIMIDE dye (NanoTemper)
and thermophoretic changes reflective of binding were as-
sessed in response to the titration of unlabeled NDR1 kinase
(Fig. 4A). As expected, nonphosphorylated MOB1AWT bound
weakly to NDR1 kinase, but this interaction could be poten-
tiated nearly 10-fold by phosphorylation (Fig. 4A i). Addition of
the predicted destabilizing mutations H24A/Q25A (small hy-
drophobic to large hydrophilic residues on the contact surface
of helix -1 with the core domain of MOB1A) partially in-
creased binding to NDR1 in the case of nonphosphorylated
MOB1A. However, full binding of the MOB1H24A/Q25A mutant
to NDR1 could still be achieved via phosphorylation by MST1,
consistent with the fact that the two regulatory sites remained
intact (Fig. 4A ii).
Deletion of the first 13 residues (encompassing the T12 site)
had no effect on nonphosphorylated MOB1A binding to
NDR1, as expected since the first 13 residues in MOB1A were
disordered in the nonphosphorylated human MOB1A struc-
ture and hence were not expected to impinge on the NDR1
interaction (Fig. 4A iii). Unexpectedly, in its phosphorylated
state, the MOB1
13 mutant displayed slightly enhanced bind-
ing to NDR1 relative to phosphorylated MOB1AWT. We hy-
pothesized that in the absence of phospho-T12 site binding to
the phosphopeptide binding pocket of MOB1A, the pT35 site
accesses the phospho-binding pocket, leading to more effi-
cient exposure of the NDR kinase binding site (Fig 4A iii). In
contrast to the N-terminal 13 residue deletion, the more ex-
pansive 38-residue deletion increased binding of nonphos-
phorylated MOB1A to NDR1. However, consistent with the
loss of both T12 and T35 phospho-regulatory sites, the
MOB1A
38 mutant was no longer responsive to phosphoryl-
ation (Fig 4A iv). Deletion of the entire 51-residue N terminus
(denoted MOB1A
51) decreased the binding affinity of non-
phosphorylated MOB1A to NDR1, which was expected since
residues 39 to 51 of the N terminus contribute to the NDR1
binding infrastructure of MOB1A (Fig. 2B, 3A and Fig. 4A v).
As observed for the MOB1A
38 mutant, phosphorylation of
the MOB1A
51 mutant had a marginal effect on NDR1 binding
(Fig. 4A v). Taken together, the above results are consistent
with the notion that in its nonphosphorylated state, the N-ter-
minal region of MOB1A restricts binding to the downstream
NDR family kinases and that mutations within this region
and/or phosphorylation of the T12 and T35 regulatory sites
promote NDR1 binding. As we observed for the phosphopep-
tide binding function of MOB1 above, the varied behavior of
MOB1 deletion mutants in NDR1 binding function raised the
possibility that differential phosphorylation of MOB1 could be
exploited for graded signaling responses in a cellular context.
Functional Consequence of the Suboptimal Match Between
the T12 Phosphosite Sequence of MOB1A and the MOB1B
Phosphopeptide-binding Consensus—Inspection of the T12
phosphosite sequence in MOB1A revealed a suboptimal
match to the MOB1B phosphopeptide binding consensus
(supplemental Fig. S5A). As expected, a pT12 peptide of
MOB1A in isolation bound only weakly to the MOB1A core
domain in trans (318M; supplemental Fig. S5A, S5C). This
finding led us to test the effect of converting the low-affinity
T12 sequence (TFKPK) in MOB1A to the high-affinity se-
quences observed in MST1 centered on the T353 and T367
sites (TMIEH & TMVIH respectively; ref 29). We reasoned that
these substitutions would give rise to a MOB1A protein that
would more potently downregulate binding to MST1 phos-
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phopeptide ligands in trans in response to MOB1A phos-
phorylation, and indeed, this is what we observed (Fig. 4B).
In their nonphosphorylated states, MOB1AT123T353 and
MOB1AT123T367 bound equally well to phosphopeptide li-
gands in trans comparable to MOB1WT. However, in response
to phosphorylation, we observed a more effective downregu-
lation of phosphopeptide binding for the high affinity site
MOB1A mutants (1000 fold downregulation of MST1 phos-
phopeptide binding versus 50-fold with WT; Fig. 4B and sup-
plemental Fig. S4B).
We next examined how mutation of the T12 and T35 phos-
pho-regulatory sites in MOB1A affected binding to the down-
FIG. 4. Mutations in the N-terminal extension of MOB1A alter binding to upstream MST1 and downstream NDR1 kinases. A,
Microscale Thermophoresis binding analysis of NDR112–418 to the indicated MOB1A mutants. Data is plotted as the mean  S.E. (n  3). B,
Fluorescence polarization binding analysis of the indicated MOB1A mutants to MST1 pT367 (top) and MST pT353 (bottom) peptides. Data is
plotted as the mean  S.E. (n  3). C, Microscale thermophoresis binding analysis of NDR112–418 to the indicated phosphorylated MOB1A
mutants. Data is plotted as the mean  S.E. (n  3).
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stream NDR family kinases. As described above, nonphos-
phorylated MOB1AWT bound to NDR1 kinase weakly, while
phospho-MOB1AWT showed an 9-fold increase in NDR1
kinase binding. Unexpectedly, rather than attenuating phos-
pho-MOB1A binding to NDR1, mutation of T12 to alanine
modestly enhanced binding (2-fold; Fig 4C). This finding
indicated that in the absence of T12 phosphorylation, phos-
pho-T35 may more effectively expose the NDR1 binding site,
presumably by allowing pT35 unrestricted access (by lack of
competition with pT12) to the MOB1A phosphopeptide bind-
ing site. This unexpected result agreed with the peculiar be-
havior of the MOB1A
13 mutant above. As expected, mutation
of T35 to alanine decreased binding of phospho-MOB1A to
NDR1 by 2-fold relative to phospho-MOB1AWT. This finding
further supported the notion that the T35 site plays a more
prominent regulatory role than the T12 site. In addition, con-
version of the T12 site to better match to the MOB1A phos-
phopeptide binding consensus gave a more potent increase
in the ability of phospho-MOB1A to bind the downstream
NDR1 kinases ( 4-fold increase relative to phospho-
MOB1AWT). This result further suggested that the T12 site is
inferior to the T35 site in regulating MOB1A function, and that
its potency can be increased by improving its binding affinity
to the phosphopeptide binding site on MOB1A (Fig. 4C). We
note that the T35 site is also an imperfect match to the
MOB1B phospho-binding consensus (supplemental Fig.
S5A; ref 29). However, we chose not to test the effect of
enhancing the match due to the complication that the re-
quired mutations would disrupt the autoinhibitory conforma-
tion of helix -1 in its nonphosphorylated state. The above
results demonstrated that the phosphorylation status of T12
and T35 dictates (in a complicated but rationalizable manner)
the ability of MOB1A to interact with both the upstream MST1
kinase and the downstream NDR1 kinase through modulation
of two distinct protein interaction surfaces on MOB1A. In
particular, the relief of autoinhibition of NDR family kinase
binding by MOB1A phosphorylation is coupled to the inhibi-
tion of MST1 kinase binding.
Functional Characterization of the N-terminal Regulatory
Tail of MOB1 in Cells Using Affinity Purification Coupled to
Mass Spectrometry—To understand how the N-terminal ex-
tension of MOB1A affects protein interactions in cells, we
generated stable cell lines with a series of MOB1A constructs
used previously in our in vitro experiments: MOB1A
38,
MOB1AT123T353, MOB1AT123T367, and a double-alanine sub-
stitution mutant at T12 and T35 (denoted MOB1AT12A/T35A).
Immunoprecipitation of these proteins (anti-FLAG) followed
by mass spectrometry showed that, as expected from our in
vitro derived model, the MOB1A
38 and MOB1AT12A/T35A mu-
tants, like MOB1AWT, efficiently interacted with upstream
Hippo components following okadaic acid treatment
(Fig. 5A; supplemental Tables S4 and S5). High-affinity
MOB1AT123T353 and MOB1AT123T367 substitution mutants
were impaired for MOB1A interaction with upstream Hippo
components as would be expected if the N-terminal extension
of MOB1A engaged its own phosphopeptide binding pocket
more tightly (Fig. 5A). All MOB1A mutants retained the ability
to interact with the downstream LATS1 and LATS2 and NDR2
kinases, however the interaction was reduced for the
MOB1AT12A/T35A mutant (Fig. 5A), as would be predicted if
these two sites could not be phosphorylated to efficiently
expose the NDR family kinase binding site on MOB1A. LATS1
and LATS2 protein levels remained equal in the MOB1A stable
cell lines (Fig. 5B) and thus any changes in protein interactions
could not be attributed to changes in protein abundance. In
summary, the behavior of MOB1A we observe in cells is
consistent with a regulatory model derived from the structural
and in vitro biophysical studies reported here.
Interestingly, our previous work also showed that phosphor-
ylation-dependent association of the PP6 phosphatase mod-
ule containing the catalytic subunit PPP6C with MOB1 was
adversely affected by mutation of the MOB1A phosphopep-
tide-binding pocket (27). This result suggested that PP6 might
engage MOB1A through a binding mechanism like that em-
ployed by MST1. However, our new data shows that the two
MOB1A mutants harboring MST1 high-affinity binding se-
quences (which had the effect of abolishing MST1 interaction)
instead resulted in an increase in PP6 module association,
which was further enhanced by okadaic acid treatment (Fig.
5A). This result indicated a more complex mode of regulation
for the MOB1-PP6 interaction (supplemental Fig. S6A) than
originally hypothesized.
Lastly, as reported in (27), the DOCK6-8 module interacted
with MOB1AWT, though the stimulatory effect of okadaic acid
on the interactions was minimal here (Fig. 5A). Strikingly, in
the absence of treatment with okadaic acid, the association of
all components of this module was greatly enhanced for the
MOB1AT123T353 and MOB1AT123T367 high-affinity substitu-
tion mutants. In contrast, interaction with the DOCK6-8 mod-
ule was reduced and nearly abolished for the MOB1A
38 and
the MOB1AT12A/T35A mutants, respectively. The lack of inter-
action detected with the MOB1AT12A/T35A mutant is consis-
tent with the findings of Mou et al., which reported that DOCK8
binds the phosphorylated form of MOB1 (32). Regarding the
stronger interactions displayed by the MOB1AT123T353 and
MOB1AT123T367 mutants, okadaic acid treatment led to a
reduction of association. In this sense, the interaction pattern
with MOB1A was more similar to the interaction pattern of
NDR and LATS family kinases (Fig. 5A and supplemental Fig.
S6B), and importantly contrasted with the interaction pattern
of MOB1A with the other two phosphorylation-dependent
modules, namely the upstream Hippo components and the
PP6 phosphatase (Fig. 5A). These surprising findings reveal
that while our in vitro studies provide a framework for under-
standing the regulatory role of phosphorylation on the inter-
action of MOB1A with the core Hippo components (MST1 and
MST2, MOB1A and MOB1B, and LATS1 and LATS2), addi-
tional structural and functional studies will be required to
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illuminate the regulated interaction mechanisms of MOB1 with
the PP6 and DOCK modules.
DISCUSSION
Our comprehensive interaction proteomic study has re-
vealed novel complexities in how MOB1A and MOB1B inter-
act with the core Hippo pathway components MST1, MST2,
LATS1, and LATS2 and with the LATS-related kinases NDR1
and NDR2 in a phospho-regulated manner to transduce sig-
nals. Our results and a great wealth of data recently published
by other groups (26, 28, 33, 36; and the accompanying paper by
ref 29) support the following sequential model for Hippo path-
way signal propagation (Fig. 6), aspects of which are general-
izable to paralogous signaling pathways across eukaryotes
such as NDR kinase signaling in metazoans and MEN in yeast.
MOB1 functions as a central coordinator of signaling by
virtue of possessing two physically distinct protein interaction
surfaces: one for engaging linear phosphopeptide epitopes
including those observed in MST1 and MST2 kinases, and a
second for engaging the globular MOB1 interacting domain of
the AGC family kinases LATS1, LATS2, NDR1, and NDR2.
MST1 and MST2 kinases, likely activated by upstream sig-
nals, have the potential to autophosphorylate on multiple sites
in the linker region between the kinase domain and the
SARAH domain. As the substrate consensus of MST1 and
MST2 kinases is a close match to the MOB1 phosphopeptide-
binding consensus, autophosphorylation of MST1 and MST2
could create docking sites that are efficiently recognized by
the phosphopeptide binding infrastructure of MOB1 (See ac-
companying paper by ref 29, for details).
Once bound to MOB1, MST1, and MST2 kinases phosphor-
ylate the N-terminal extension of MOB1, minimally on two
key phospho-regulatory sites, T12 and T35, both of which
closely match the substrate consensus of MST1 and MST2,
but poorly match the phosphopeptide binding consensus of
MOB1 itself (See accompanying paper by ref 29). These
events induce a switch-like conformational change in the
N-terminal extension of MOB1 that exposes the binding sur-
face for NDR and LATS kinases while concomitantly blocking
the phosphopeptide-binding infrastructure of MOB1. The lat-
ter causes the coordinated release of MST1 and MST2.
FIG. 5. Cell-based interaction analysis of MOB1A mutants. A, Interaction profiles of FLAG-MOB1A and the indicated MOB1A N-terminal
extension mutants, affinity-purified from stable HEK293 cell lines after treatment with okadaic acid (OA) or DMSO vehicle controls. Statistical
analysis of the interaction confidence was performed using SAINTexpress (49) and visualization was through prohits-viz.lunenfeld.ca (see
Experimental Procedures). Interactions are listed for the upstream Hippo kinase module, LATS and NDR kinases, DOCK6-8 and PP6
phosphatase modules. See inset legend for details. All interactions are listed in supplemental Table S4 and the underlying protein identifications
in supplemental Table S5. Also see ProHits-web.lunenfeld.ca (project: “phospho-dependent Hippo interactions”). B, Control Western blot
analysis of FLAG-MOB1A and endogenous PPP6C, LATS1 and LATS2 expression levels.
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Prior to the release of MST1 and MST2 from MOB1, the
transient binding of both upstream and downstream kinases
allows MST1 and MST2 to phosphorylate the LATS and NDR
kinases on the hydrophobic motif (HM) (as amply discussed in
prior studies, ref 17, 20, 21–25), thereby facilitating their ac-
tivation and the propagation of downstream signals, including
through the phosphorylation of YAP1 and TAZ by LATS ki-
nases in the Hippo pathway (Fig. 6).
Our results also highlight greater complexity than antici-
pated in the regulation of phospho-dependent interactions
surrounding MOB1. We previously discovered that mutation
of the basic residues in the MOB1B phosphopeptide binding
pocket (MOB1KRR33A) abrogated okadaic acid-induced inter-
action of MOB1B with MST1 and MST2 kinases, as well as
with the PP6 regulatory subunit PPP6R3. This suggested a
common binding mode in which PP6, MST1 and MST2 bind
to the same phospho-recognition infrastructure on MOB1B
(27). However, contradicting this inference, our new in-
teraction proteomics results reveal that the hig-affinity
MOB1AT123T353 and MOB1AT123T367 substitution mutants
abolish the interaction with the MST1 and MST2 kinases (fully
consistent with our predictions) while increasing the interac-
tion with members of the PP6 complexes. This result supports
the presence of a distinct and novel binding mode for PP6, the
structural basis of which warrants future investigation. Simi-
larly, based on the increase in interaction reported previously
between MOB1 and the DOCK6-8 module following okadaic
acid treatment (27) and the fact that the interaction of MOB1
with this module was mutually exclusive with its interaction
with the upstream Hippo components and with the PP6 mod-
ule, we hypothesized that the DOCK6-8 module may share
the same mode of binding to MOB1 as MST1 and MST2.
However, the results in Fig. 5 clearly indicate a dissimilar
mode of binding of DOCK6-8 to MOB1 that instead resembles
that of the LATS and NDR kinases. Whether either of the PP6
and DOCK6-8 modules feeds into the Hippo pathway or
instead impart altogether novel and unrelated functions of
MOB1 remains to be determined.
Why is the pathway constructed in a manner that appar-
ently minimizes concurrent binding of the upstream MST1
kinase and the downstream NDR and LATS kinases to
MOB1? Perhaps this design allows MOB1 to act in a catalytic
manner whereby the forced release of MST1 from MOB1 can
facilitate MST1 interaction with multiple MOB1 proteins,
thereby enabling the activation of multiple LATS and NDR
kinases. If true, then enhancing the concurrent binding of
MST1 and LATS1 kinases to MOB1 would be predicted to
inhibit Hippo pathway signal propagation. Alternatively, the
enforcement of mutually-exclusive binding of MST1 and LATS
and NDR kinases to MOB1 may serve as means to limit the
propagation of signal. If this were the case, then an enhance-
ment of concurrent binding of MST1 and LATS1 to MOB1
would be predicted to enhance Hippo pathway signaling.
While not fully addressed in the current study, our results
provide a framework to dissect this fundamental question of
pathway design, with major implications for the development
of therapeutic intervention strategies to restrain unbridled cell
proliferation.
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